The identification of in vitro metabolites of CKD-732 by liquid chromatography/tandem mass spectrometry

被引:10
作者
Myung, SW
Kim, HY
Min, HK
Kim, DH
Kim, M
Cho, HW
Lee, HS
Kim, JK
Hong, CI
机构
[1] Korea Inst Sci & Technol, Doping Control Ctr, Seoul 136791, South Korea
[2] KyongGi Univ, Dept Chem, Suwon 442760, Kyonggi Do, South Korea
[3] Chong Kun Dang Res Inst, Cheonan Si, Chungcheongnam, South Korea
关键词
D O I
10.1002/rcm.830
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The structural elucidation of fourteen metabolites of CKD-732, formed in vitro with rat liver microsomes, was performed using high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry (HPLC/ESI-MS/MS). To identify proposed structures of the metabolites, the product ion mass spectra of the protonated molecules ([M + H](+)), the retention times on reversed-phase HPLC, and UV-Vis spectra were utilized. Characteristic product ions for the identification of CKD-732 metabolites were observed at m/z 231, 236, and 252. The fragment ions at m/z 236 and 252 indicated the unchanged form and the N-oxide of the dimethylamino-ethoxycinnamoyl group, respectively. The ion at m/z 231 indicated the presence of the hydroxylated form of the fumagillol group. The N-oxide of CKD-732, which was detected at m/z 515 and eluted later than CKD-732 in the reversed-phase HPLC system, was measured as a major metabolite. Three cis-trans isomers were also found. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:2048 / 2053
页数:6
相关论文
共 10 条
[1]   ASSAY OF THE ANTIANGIOGENIC COMPOUND TNP-470, AND ONE OF ITS METABOLITES, AGM-1883, BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY IN PLASMA [J].
FIGG, WD ;
YEH, HJC ;
THIBAULT, A ;
PLUDA, JM ;
ITOH, F ;
YARCHOAN, R ;
COOPER, MR .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 652 (02) :187-194
[2]   In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry [J].
Hop, CECA ;
Tiller, PR ;
Romanyshyn, L .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2002, 16 (03) :212-219
[3]   SYNTHETIC ANALOGS OF FUMAGILLIN THAT INHIBIT ANGIOGENESIS AND SUPPRESS TUMOR-GROWTH [J].
INGBER, D ;
FUJITA, T ;
KISHIMOTO, S ;
SUDO, K ;
KANAMARU, T ;
BREM, H ;
FOLKMAN, J .
NATURE, 1990, 348 (6301) :555-557
[4]  
Lang WS, 2000, DRUG METAB DISPOS, V28, P899
[5]   Determination of O-(chloroacetylcarbamoyl)fumagillol (TNP-470;AGM-1470) and two metabolites in plasma by high-performance liquid chromatography mass spectrometry with atmospheric pressure chemical ionization [J].
Moore, JD ;
Sommadossi, JP .
JOURNAL OF MASS SPECTROMETRY, 1995, 30 (12) :1707-1715
[6]   Quantitation of TNP-470 and its metabolites in human plasma: sample handling, assay performance and stability [J].
Ong, VS ;
Stamm, GE ;
Menacherry, S ;
Chu, SY .
JOURNAL OF CHROMATOGRAPHY B, 1998, 710 (1-2) :173-182
[7]  
PLACIDI L, 1995, CANCER RES, V55, P3036
[8]  
Placidi L, 1999, DRUG METAB DISPOS, V27, P623
[9]  
Placidi L, 1997, DRUG METAB DISPOS, V25, P94
[10]  
SCOTT EC, 1996, CANCER CHEMOTH PHARM, V38, P117